Updated

PL

News

New analysis: waiting lists for drug programmes.

At the end of September 2026, between 9,000 and 12,000 people were waiting for treatment in drug programmes. Usually a few weeks, but much longer in some programmes and regions, and the ministry does not know how many patients are waiting because a hospital’s contract has run out.

Five identical drip stands in a row; only the nearest one holds an infusion bag, the hooks of the others are empty

There is a new analysis on the site: Waiting lists for drug programmes: weeks on average, but not everywhere. It describes how many patients are waiting for expensive hospital treatment, for how long and why. It is based on the NFZ files with waiting lists, data from the Polish Society for Rheumatology and answers from the Ministry of Health.

What it shows

  • At the end of September 2026, 9,137 people were on the list, and 11,935 including one hospital whose data need explaining. People admitted in September had waited 33.2 days on average.
  • In rheumatology, where you live decides how long you wait. 57% of qualified patients in Lower Silesia had not received their first dose of the drug, compared with 1% in the Lublin region.
  • NFZ spending on drugs in these programmes has risen more than fourfold since 2017, to PLN 13.95 billion in 2025. Hospital contracts are capped, however, and PLN 1.08 billion of treatment above the cap in the first half of 2026 was still waiting to be settled.
  • The Ministry of Health and the NFZ have no data on how many patients are waiting because a hospital’s contract has run out.

What else is in the text

Where records of a thousand days come from and why they do not measure waiting time, what cancer hospitals say and what a patient waiting for treatment can do. Every figure is sourced in the footnotes.

Popular